Neurizon Therapeutics (ASX:NUZ) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Neurizon Therapeutics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Neurizon Therapeutics's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Neurizon Therapeutics's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).

Neurizon Therapeutics LT-Debt-to-Total-Asset Historical Data

The historical data trend for Neurizon Therapeutics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics LT-Debt-to-Total-Asset Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.18

0.02

0.01

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.10	0.10	-	-	-

Neurizon Therapeutics LT-Debt-to-Total-Asset Calculation

Neurizon Therapeutics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2005 is calculated as

LT Debt to Total Assets (A: Jun. 2005 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2005 )	/	Total Assets (A: Jun. 2005 )
	=	0.057	/	5.275
	=	0.01

Neurizon Therapeutics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	0	/	15.529
	=

Neurizon Therapeutics (ASX:NUZ) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Neurizon Therapeutics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (ASX:NUZ) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

ECQ0:Germany

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines